- Home
- NGS vs ENGN Comparison
NGS vs ENGN Comparison
Compare NGS & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGS
- ENGN
- Stock Information
- Founded
- NGS 1998
- ENGN 1999
- Country
- NGS United States
- ENGN Canada
- Employees
- NGS N/A
- ENGN N/A
- Industry
- NGS Oilfield Services/Equipment
- ENGN
- Sector
- NGS Energy
- ENGN
- Exchange
- NGS Nasdaq
- ENGN Nasdaq
- Market Cap
- NGS 305.2M
- ENGN 321.5M
- IPO Year
- NGS 2002
- ENGN N/A
- Fundamental
- Price
- NGS $27.27
- ENGN $6.07
- Analyst Decision
- NGS Strong Buy
- ENGN Buy
- Analyst Count
- NGS 3
- ENGN 8
- Target Price
- NGS $33.67
- ENGN $21.50
- AVG Volume (30 Days)
- NGS 48.8K
- ENGN 222.4K
- Earning Date
- NGS 11-13-2025
- ENGN 09-11-2025
- Dividend Yield
- NGS 1.46%
- ENGN N/A
- EPS Growth
- NGS 33.85
- ENGN N/A
- EPS
- NGS 1.42
- ENGN N/A
- Revenue
- NGS $164,109,000.00
- ENGN N/A
- Revenue This Year
- NGS $9.86
- ENGN N/A
- Revenue Next Year
- NGS $14.21
- ENGN N/A
- P/E Ratio
- NGS $19.25
- ENGN N/A
- Revenue Growth
- NGS 14.77
- ENGN N/A
- 52 Week Low
- NGS $16.73
- ENGN $2.65
- 52 Week High
- NGS $29.74
- ENGN $11.00
- Technical
- Relative Strength Index (RSI)
- NGS 61.86
- ENGN 56.13
- Support Level
- NGS $26.25
- ENGN N/A
- Resistance Level
- NGS $26.89
- ENGN $6.54
- Average True Range (ATR)
- NGS 0.72
- ENGN 0.50
- MACD
- NGS 0.05
- ENGN -0.12
- Stochastic Oscillator
- NGS 89.78
- ENGN 92.74
About NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.